Dr. Sharon Adler is internationally known for her experimental and clinical research in all aspects of diabetic kidney disease and glomerulonephritis. Her current work focuses on discerning why patients with even mild kidney disease suffer death and disability from heart disease. She recently discovered molecules in the urine that facilitate the identification of kidney disease early on; this discovery is expected to open up new avenues for the treatment of kidney disease.
Read more »
- M.D., 1976, State University of New York (SUNY) Downstate, Medical Center College Of Medicine
- Post-Doctoral Fellow, 1983, Los Angeles County Harbor-UCLA Medical Center
- Residency, 1980, Loma Linda University Medical Center
- Internship, 1977, Long Island Jewish Hospital
- Professor of Medicine, David Geffen School of Medicine, Harbor-UCLA Medical Center
- Associate Director, Division of Nephrology and Hypertension
- Program Director, Nephrology Fellowship Training Program
- Chief, Division of Nephrology and Hypertension
- Principal Investigator, LA BioMed
AWARDS & RECOGNITIONS
Regents Scholarship, 1968-72
Barnard College Dean’s List, 1970-72
Harbor-UCLA Collegium Research Award, 1984
Los Angeles Magazine
- Best Doctors in L.A., Southern California Super Doctors 2008 – 2010
- Best Doctors in America – Pacific Region, 1996 – 2011
- Top Women Southern California Super Doctors, 2011
Recent and/or Significant Studies:
Change in ankle-brachial index over time and mortality in diabetics with proteinuria.
Jiwakanon S, Adler S, Mehrotra R.
Clin Nephrol. 2012 Jul 12.
Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium.
Satirapoj B, Bruhn KW, Nast CC, Wang Y, Dai T, Lapage J, Wu X, Natarajan R, Adler SG.
Am J Nephrol. 2012;35(6):520-30. Epub 2012 May 25.
Novel insights into the relationship between glomerular pathology and progressive kidney disease.
Satirapoj B, Nast CC, Adler SG.
Adv Chronic Kidney Dis. 2012 Mar;19(2):93-100. Review.